277 related articles for article (PubMed ID: 15790664)
21. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.
Perrière N; Yousif S; Cazaubon S; Chaverot N; Bourasset F; Cisternino S; Declèves X; Hori S; Terasaki T; Deli M; Scherrmann JM; Temsamani J; Roux F; Couraud PO
Brain Res; 2007 May; 1150():1-13. PubMed ID: 17434463
[TBL] [Abstract][Full Text] [Related]
22. Establishment of a new conditionally immortalized cell line from human brain microvascular endothelial cells: a promising tool for human blood-brain barrier studies.
Kamiichi A; Furihata T; Kishida S; Ohta Y; Saito K; Kawamatsu S; Chiba K
Brain Res; 2012 Dec; 1488():113-22. PubMed ID: 23041702
[TBL] [Abstract][Full Text] [Related]
23. Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endothelial cEND cells.
Blecharz KG; Drenckhahn D; Förster CY
J Cereb Blood Flow Metab; 2008 Jun; 28(6):1139-49. PubMed ID: 18231113
[TBL] [Abstract][Full Text] [Related]
24. Ketamine alleviates bradykinin-induced disruption of the mouse cerebrovascular endothelial cell-constructed tight junction barrier via a calcium-mediated redistribution of occludin polymerization.
Chen JT; Lin YL; Chen TL; Tai YT; Chen CY; Chen RM
Toxicology; 2016 Aug; 368-369():142-151. PubMed ID: 27638051
[TBL] [Abstract][Full Text] [Related]
25. Stabilization of brain microvascular endothelial barrier function by shear stress involves VE-cadherin signaling leading to modulation of pTyr-occludin levels.
Walsh TG; Murphy RP; Fitzpatrick P; Rochfort KD; Guinan AF; Murphy A; Cummins PM
J Cell Physiol; 2011 Nov; 226(11):3053-63. PubMed ID: 21302304
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoid insensitivity at the hypoxic blood-brain barrier can be reversed by inhibition of the proteasome.
Kleinschnitz C; Blecharz K; Kahles T; Schwarz T; Kraft P; Göbel K; Meuth SG; Burek M; Thum T; Stoll G; Förster C
Stroke; 2011 Apr; 42(4):1081-9. PubMed ID: 21330632
[TBL] [Abstract][Full Text] [Related]
27. In vitro models of the blood-brain barrier.
Czupalla CJ; Liebner S; Devraj K
Methods Mol Biol; 2014; 1135():415-37. PubMed ID: 24510883
[TBL] [Abstract][Full Text] [Related]
28. Interleukin 6-Mediated Endothelial Barrier Disturbances Can Be Attenuated by Blockade of the IL6 Receptor Expressed in Brain Microvascular Endothelial Cells.
Blecharz-Lang KG; Wagner J; Fries A; Nieminen-Kelhä M; Rösner J; Schneider UC; Vajkoczy P
Transl Stroke Res; 2018 Dec; 9(6):631-642. PubMed ID: 29429002
[TBL] [Abstract][Full Text] [Related]
29. Influence of basolateral condition on the regulation of brain microvascular endothelial tight junction properties and barrier function.
Colgan OC; Collins NT; Ferguson G; Murphy RP; Birney YA; Cahill PA; Cummins PM
Brain Res; 2008 Feb; 1193():84-92. PubMed ID: 18177846
[TBL] [Abstract][Full Text] [Related]
30. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells.
András IE; Pu H; Deli MA; Nath A; Hennig B; Toborek M
J Neurosci Res; 2003 Oct; 74(2):255-65. PubMed ID: 14515355
[TBL] [Abstract][Full Text] [Related]
31. Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells.
Nagasawa K; Chiba H; Fujita H; Kojima T; Saito T; Endo T; Sawada N
J Cell Physiol; 2006 Jul; 208(1):123-32. PubMed ID: 16547974
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of bEnd5 cell line as an in vitro model for the blood-brain barrier under normal and hypoxic/aglycemic conditions.
Yang T; Roder KE; Abbruscato TJ
J Pharm Sci; 2007 Dec; 96(12):3196-213. PubMed ID: 17828743
[TBL] [Abstract][Full Text] [Related]
33. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
[TBL] [Abstract][Full Text] [Related]
34. Cyclic strain-mediated regulation of vascular endothelial occludin and ZO-1: influence on intercellular tight junction assembly and function.
Collins NT; Cummins PM; Colgan OC; Ferguson G; Birney YA; Murphy RP; Meade G; Cahill PA
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):62-8. PubMed ID: 16269664
[TBL] [Abstract][Full Text] [Related]
35. Hydrogen peroxide-induced alterations of tight junction proteins in bovine brain microvascular endothelial cells.
Lee HS; Namkoong K; Kim DH; Kim KJ; Cheong YH; Kim SS; Lee WB; Kim KY
Microvasc Res; 2004 Nov; 68(3):231-8. PubMed ID: 15501242
[TBL] [Abstract][Full Text] [Related]
36. Altered expression of tight junction proteins and matrix metalloproteinases in thiamine-deficient mouse brain.
Beauchesne E; Desjardins P; Hazell AS; Butterworth RF
Neurochem Int; 2009 Sep; 55(5):275-81. PubMed ID: 19576514
[TBL] [Abstract][Full Text] [Related]
37. Transmembrane proteins of the tight junctions at the blood-brain barrier: structural and functional aspects.
Haseloff RF; Dithmer S; Winkler L; Wolburg H; Blasig IE
Semin Cell Dev Biol; 2015 Feb; 38():16-25. PubMed ID: 25433243
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoids and endothelial cell barrier function.
Salvador E; Shityakov S; Förster C
Cell Tissue Res; 2014 Mar; 355(3):597-605. PubMed ID: 24352805
[TBL] [Abstract][Full Text] [Related]
39. Assessments of tight junction proteins occludin, claudin 5 and scaffold proteins ZO1 and ZO2 in endothelial cells of the rat blood-brain barrier: cellular responses to neurotoxicants malathion and lead acetate.
Balbuena P; Li W; Ehrich M
Neurotoxicology; 2011 Jan; 32(1):58-67. PubMed ID: 20970449
[TBL] [Abstract][Full Text] [Related]
40. Co-culture based blood-brain barrier in vitro model, a tissue engineering approach using immortalized cell lines for drug transport study.
Zhang Z; McGoron AJ; Crumpler ET; Li CZ
Appl Biochem Biotechnol; 2011 Jan; 163(2):278-95. PubMed ID: 20652765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
